Open original FDA record ↗Recall record
- FDA identifier
- Z-0091-2023
- Company in FDA record
- B. Braun Medical, Inc.
- FDA classification date
- Oct 14, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The extension set has a high probability of failure which could lead to possible leakage or detachment at the device's bonded joint during use. The issue may result in delay of therapy, increased risk of bloodstream infections (BSI), and may expose both patients and healthcare workers to hazardous medications. Depending on the nature of the leak and type of infusion, there is also the potential for life-threatening situations to occur including air embolization or hypovolemia.
Source facts
- Action
- On September 15, 2022, the firm notified affected customers via Urgent Medical Device Recall letters. Customers were instructed to cease use and quarantine the product subject to recall. Once customers have returned the completed acknowledgement form to B. Braun Medical Inc., a Customer Support representative will contact the customer with instructions on returning impacted cases. The firm will provide credit and/or replacement of the product based on the customer's needs. For questions, please contact BBMI's Postmarket Surveillance Department at 1-833-425-1464.
- Initiated
- 2022-09-15
- Root cause
- Process design
- Distribution
- Distribution US nationwide, Canada and Saudi Arabia.
- Recall number
- Z-0091-2023
- Recall status
- Open, Classified
- CDRH record ID
- 196060
- FDA classified
- 2022-10-14
- Recall event number
- 90850